In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents.
Topically-applied antioxidant drugs represent a successful strategy for protecting the skin against UV-mediated oxidative damage. However, they can afford to the skin a satisfactory photoprotection only if able to permeate through the stratum corneum and thus to reach deeper cutaneous layers. Caffeic and ferulic acids, dissolved in saturated aqueous solutions at pH 3 or 7.2, have been tested for their capability to permeate through excised human skin mounted in Franz cells. At both pH values, ferulic and, at a lower degree, caffeic acids appeared able to permeate through the stratum corneum. The known higher lipophilicity of ferulic acid may explain the fact that it permeates through the stratum corneum better than caffeic acid. However, vehicle pH values proved to have no influence on biophenol skin permeation profile; this observed lack of pH effect may reflect the drug higher concentration attainable in saturated solutions at high pH. On the basis of the findings obtained in these in vitro experiments, we designed the schedule of a series of in vivo experiments, carried out to evaluate the ability of caffeic and ferulic acids to reduce, in healthy human volunteers, UVB-induced skin erythema, monitored by means of reflectance spectrophotometry. Caffeic and ferulic acids, dissolved in saturated aqueous solution pH 7.2, proved to afford a significant protection to the skin against UVB-induced erythema. To conclude, we have confirmed, by means of in vitro and in vivo experiments, that caffeic and ferulic acids may be successfully employed as topical protective agents against UV radiation-induced skin damage; however their skin absorption is not influenced by the pH of the formulation.
Saija
A
A
Department of Pharmacology of Natural Substances and General Physiology, University of Rome 'La Sapienza', Rome, Italy. saija@pharma.unime.it
Tomaino
A
A
Trombetta
D
D
De Pasquale
A
A
Uccella
N
N
Barbuzzi
T
T
Paolino
D
D
Bonina
F
F
D000287:Administration, Topical; D000328:Adult; D019540:Area Under Curve; D002109:Caffeic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003373:Coumaric Acids / Q000008:administration & dosage / Q000494:pharmacology*; D004890:Erythema / Q000517:prevention & control; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D012869:Skin Absorption; D013056:Spectrophotometry, Ultraviolet; D013473:Sunscreening Agents / Q000008:administration & dosage / Q000494:pharmacology*; D014466:Ultraviolet Rays
D002109:Caffeic Acids; D003373:Coumaric Acids; D013473:Sunscreening Agents; C004999:ferulic acid; C040048:caffeic acid